EU Database Monitoring Highlights Updates to Poultry Vaccines and Pig Medicine

EUROPEAN UNION | 16 October 2026 — The European Union’s Veterinary Medicines Information website, maintained on behalf of the EU medicines regulatory network by the European Medicines Agency (EMA), is being monitored for database updates involving poultry vaccines and medicines used in pigs.

The products identified in the reported update list are HIPRAGUMBORO-CH/80, HIPRAVIAR-CLON/H120, HIPRAVIAR-S and HIPRAVIAR SHS, alongside LAMULIN 450 mg/g granules for pigs. These entries are relevant to poultry-health and swine-health stakeholders tracking veterinary product information, authorisation records and documentation changes.

The EU’s Veterinary Medicines Information website provides product-specific information, including authorised species, active substances, pharmaceutical forms, marketing-authorisation details and product documents. Its What’s new section records medicines marked as new or updated. Official EU Veterinary Medicines Information website.

Poultry vaccines cover important disease-control areas

The named HIPRA products relate to different poultry-health applications. HIPRAGUMBORO-CH/80 contains a live infectious bursal disease virus strain and is used in the context of infectious bursal disease vaccination. HIPRAVIAR S/H120 is a live vaccine against Newcastle disease and infectious bronchitis, while HIPRAVIAR SHS is associated with turkey rhinotracheitis and swollen-head syndrome. Product indications and permitted use depend on the specific authorised formulation and national product information.

These vaccines form part of the broader toolkit used by poultry veterinarians and producers to manage infectious disease risks. Vaccination programmes must be matched to the target species, production system, local disease situation and approved label instructions.

Pig-medicine listing requires product-name verification

The reported list also includes a 450 mg/g granule medicine described as LAMULIN for pigs. Before publication or regulatory action, the exact name and formulation should be checked against the relevant database record. The EU database separately lists Vetmulin 450 mg/g Granules for Use in Drinking Water for Pigs, Chickens and Turkeys, containing tiamulin hydrogen fumarate, while a product named Lamulin is listed at a different strength. The names and formulations should not be treated as interchangeable.

Veterinary antimicrobials such as tiamulin are subject to authorised-use conditions, prescription requirements and product-specific directions. Their use should follow the applicable product information and veterinary guidance.

What a database update means

A database entry marked “updated” does not, by itself, mean that a medicine has received a new marketing authorisation, a new indication, a label expansion or a new regulatory approval. An update can involve product information or other administrative documentation. The nature and significance of each change must be established from its individual record and associated documents.